B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1286-1292

  Morbidelli, Lucia ^a   Parenti, Astrid ^a   Giovannelli, Lisa ^a   Granger, Harris J ^b   Ledda, Fabrizio ^a   Ziche, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

B1 and B2 receptors; Bradykinin; Fibroblast growth factor 2; Migration; Postcapillary endothelial cells; Proliferation

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ RECEPTOR AGONIST; DNA; FIBROBLAST GROWTH FACTOR 2; ICATIBANT; KALLIDIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; IMMUNOREACTIVITY; MITOGENESIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; BRADYKININ; CATTLE; CELL MOVEMENT; CELLS, CULTURED; DNA REPLICATION; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; URINARY PLASMINOGEN ACTIVATOR; VENULES;

EID: 0031874006     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701943     Document Type: Article

References (33)

1. COHEN, M.V. & DOWNEY, J.M. (1996). Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu. Rev. Med. 47, 21-29.
2. DIXON, B.S. & DENNIS, M.J. (1997). Regulation of mitogenesis by kinins in arterial smooth muscle cells. Am. J. Physiol., 273, C7-C20.
3. DRUMMOND, G.R. & COCKS, T.M. (1995). Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br. J. Pharmacol., 116, 2473-2481.
4. DUSSEAU, J.W., HUTCHINS, P.M. & MALBASA, D.S. (1986). Stimulation of angiogenesis by adenosine on chick chorioallantoic membrane. Circ. Res., 59, 163-170.
5. EL-DAHR, S.S. DIPP, S., YOSIPIV, I.V. & BARICOS, W.H. (1996). Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells. Kidney Int., 50, 1850-1855.
6. FOLKMAN, J. (1982). Angiogenesis: initiation and control. Ann. N.Y. Acad. Sci., 401, 212-227.
7. FOLKMAN, J. & SHING, Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
8. GOLDSTEIN, R.H. & WALL, M. (1984). Activation of protein formation and cell division by bradykinin and Des-Arg9-bradykinin. J. Biol. Chem., 259, 9263-9268.
9. GRANGER, H.J., ZICHE, M., HAWKER, JR. Jr, MEININGER, C.J., CZISNY, L.E. & ZAWIEJA, D.C. (1994). Molecular and cellular basis of myocardial angiogenesis. Cell. Mol. Biol. Res., 40, 81-85.
10. HALL, J.M. (1992). Bradykinin receptors: pharmacological and biological roles. Pharmac. Ther., 56, 131-190.
11. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, ST. BREIPOHL, G., KONIG, W., KNOLLE, J. & SCHOLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 796-773.
12. HU, D.-E., & FAN, T.-P.D. (1993). [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats Br. J. Pharmacol., 109, 14-17.
13. 133Xe clearance, blood flow and histology in rat sponge model of angiogenesis. Lab. Invest., 72, 601-610.
14. KIMBALL, E.S. & FISHER, M.C. (1988). Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides. J. Immunol., 141, 4203-4208.
15. LE NOBLE, F.A.C., SCHREURS, N.H.J.S., VAN STRAATEN, H.W.M., SLAAF, D.W. & STRUIJKER-BOUDIER, H.A.J. (1993). Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol., 264, R460-R465.
16. MARCEAU, F. & TREMBLAY, B. (1986). Mitogenic effect of bradykinin and Des-Arg9-bradykinin on cultured fibroblasts. Life Sci., 39, 2351-2358.
17. MARTORANA, P.A., KETTENBACH, B., BREIPOHL, G., LINZ, W. & SCHOLKENS, B.A. (1990). Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur. J. Pharmacol., 182, 395-396.
18. B receptors. Am. J. Physiol., 269, H686-H695.
19. NODA, K., SASAGURI, M., IDEISHI, M., IKEDA, M. & ARAKAWA, K. (1993). Role of locally informed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc. Res., 27, 334-340.
20. PATEL, K.V. & SCHREY, M.P. (1992). Inhibition of DNA synthesis and growth in human breast stromal cells by bradykinin: evidence for independent roles of B1 and B2 receptors in the respective control of cell growth and phospholipid hydrolysis. Cancer Res., 52, 334-340.
21. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
22. REGOLI, D., GOBEIL, F., NGUYEN, Q.T., JUKIC, D., SEOANE, P.R., SALVINO, J.M. & SAWUTZ, D.J. (1994). Bradykinin receptor types and B2 subtypes. Life Sci., 55, 735-749.
23. SCHELLING, M.E., MEININGER, C.J., HAWKER, J.R. & GRANGER, H.J. (1988). Venular endothelial cells from bovine heart. Am. J. Physiol., 254, H1211-H1217.
24. SCHNERCK, K.A., HESS, J.E., STONESIFER, G.Y. & RANSOM, R.W. (1994). Bradykinin B1 receptors in the rabbit aorta smooth muscle cells in culture. Eur. J. Pharmacol., 266, 277-282.
25. SCHRIEFER, J.A., BROUDY, E.P. & HASSEN, A.H. (1997). Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model. J. Pharmacol. Exp. Ther., 278, 1034-1039.
26. STARKOPF, J., BUGGE, E. & YTREHUS, K. (1997). Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart. Cardiovasc. Res., 33, 63-70.
27. VEGH, A., SZEKERES, L. & PARRAT, J. (1991). Local intracoronary infusion of bradykinin profoundly reduces the severity of ischemia-induced arrhythmias in anaesthetized dogs. Br. J. Pharmacol., 104, 294-295.
28. YAU, L., PINSK, M. & ZAHRADKA, P. (1996). Inhibition of RNA synthesis by bradykinin involves both the B1 and B2 receptor subtypes. Arch. Biochem. Biophys., 328, 115-121.
29. YELLON, D.M., ALKHULAIFI, A.M. & PUGSLEY, W.B. (1993). Preconditioning the human myocardium. Lancet, 342, 276-277.
30. ZICHE, M., MORBIDELLI, L. & DONNINI, S. (1996). Angiogenesis. Exp. Nephrol., 4, 1-14.
31. ZICHE, M., MORBIDELLI, L., MASINI, E., AMERINI, S., GRANGER, H.J., MAGGI, C.A., GEPPETTI, P. & LEDDA, F. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94, 2036-2044.
32. ZICHE, M., MORBIDELLI, L., PARENTI, A., AMERINI, S., GRANGER, H.J. & MAGGI, C.A. (1993). Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci., 53, 1105-1112.
33. ZICHE, M., PARENTI, A., LEDDA, F., DELL'ERA, P., GRANGER, H.J., MAGGI, C.A. & PRESTA, M. (1997). Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res., 80, 845-852.